Introduction
Deliberate self-poisoning is a major health problem worldwide and is a common reason for young adults to be admitted to hospital. 1, 2 The UK has one of the highest rates of deliberate drug overdose in Europe. 1 The epidemiology of self-poisoning varies between countries [3] [4] [5] [6] [7] [8] [9] and changes over time. 10 These changes are related to both trends in prescribing and, increasingly, to the availability of illicit substances. 11 Intensive care unit (ICU) management of the patient with poisoning requires rapid diagnosis and supportive care while providing specific antidotal treatment in some cases. 2, 12, 13 In the past 25 years, epidemiological studies of patients admitted to ICU after self-poisoning have been published from mainland Europe and Ireland, 8, [14] [15] [16] Australia 9, 17 and Asia 4,5 but no studies have been performed in the UK. We performed a retrospective observational study of patients with selfpoisoning admitted to the ICU at the Royal Infirmary of Edinburgh (RIE), UK. Our aim was to review the epidemiology and outcomes of these patients and relate this to previously established international patterns.
Methods
The chairman of the local research and ethics committee stated that formal ethical approval and written informed consent were not required for this retrospective case series.
Setting
The RIE is a tertiary teaching hospital, which serves a population of around 750,000. Poisoned patients are admitted via the emergency department (ED), which is the single ED in the city of Edinburgh. The ICU has 13 funded intensive care beds (level 3) and 17 funded high dependency beds (level 2). The ICU admits adults (≥13 years of age) with critical illness, except those after cardiac surgery, those with uncomplicated cardiological problems and those with isolated head injury. The unit admits around 2,500 patients each year, of whom around 900 (36%) require level 3 care. The Scottish Intensive Care Society WardWatcher TM database is used to record epidemiological data on all patients including reason for admission, diagnosis, patient outcome and predicted mortality. The RIE is also the site of the Scottish Liver Transplant Unit (SLTU).
Population
All patients admitted to the RIE ICU between 1 January 2005 and 31 December 2009 were reviewed. During this period, 12,702 patients were admitted, of whom 4,713 (37%) required
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Review design
The records of these 481 patients were reviewed to obtain the following information: age; gender; substances taken; organ support used; critical care and hospital outcomes. If available, Glasgow Coma Scale (GCS) score on presentation to hospital, Acute Physiology and Chronic Health Evaluation (APACHE) II score, predicted mortality, the results of any toxicology investigations and the results of computed tomography (CT) brain scanning were recorded.
Statistical analysis
Statistical calculations and resultant graphical illustrations were created using Microsoft Excel (Microsoft Inc., 2003) .
Results
The demographic, physiological, treatment and outcome data for the 481 poisoned patients are presented in Table 1 . There were 394 patients who required level 3 care and 87, level 2 care. The male:female ratio was 1.44:1. The age distribution of patients is shown in Figure 1 .
Twenty-three patients (5%) were admitted to ICU on more than one separate occasion. Sixteen patients were admitted on
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Age in years 37 (27, 46) Gender, male:female 284:197 GCS at presentation (n=436) 7 (4, 10)
APACHE II score (n=377) 14 (9, 19) APACHE II predicted mortality (%) 0.9 (0.4, 2.5)
Inotropic support (n, %) 29 (6) Renal replacement therapy (n, %) 29 (6) Intensive care length of stay in days 0.7 (0.5, 1.4)
Intensive care mortality (n, %) 15 (3%)
Hospital mortality (n, %) 20 (4%)
Discharged directly home from intensive care (n, %) 58 (12) Transferred to psychiatric hospital (n, %) 46 (10) two occasions, three patients on three occasions, three patients on four occasions and one patient on five occasions. One of these patients died in hospital during their second admission. Excluding alcohol, the median number (range) of substances taken per patient was 2 (1-9) (Figure 2 ). Details of the substances reported are shown in Table 2 . There were 195 (41%) patients admitted due to alcohol consumption. In 37 patients (31 male, 6 female), alcohol was the only substance ingested. One hundred and ten patients reported illicit drug use during their act of self-harm or recreational misadventure. The substances reported were: heroin 26, methadone 25, gamma hydroxybutyrate (GHB) 26, gamma butyrolactone (GBL) 3, ecstasy 18, cocaine 13, amphetamine 3, cannabis 1, lysergic acid diethylamide (LSD) 1, and unknown 7.
GCS at hospital presentation was recorded in 436 patients. The median (IQR) GCS for all patients was 7 (4, 10). In patients who required level 3 care, the median GCS was 6 (4, 8) and for those requiring level 2 care, median GCS was 14 (10, 15) . APACHE II score and predicted mortality were recorded in 377 of the 394 patients who required level 3 care. Median (IQR) APACHE II score was 14 (9, 19) with a predicted mortality of 0.9% (0.4, 2.5%).
Patient outcomes
Median length of stay in the ICU for all patients was 0.7 days; 306 patients had a length of stay less than 24 hours. Fifty-seven patients (12%) remained in intensive care longer than 48 hours; of these patients, only two had their discharge delayed owing to lack of available ward beds. A total of 461 patients (96%) survived to discharge from hospital; fifty-eight patients (12%) were discharged home directly from ICU and 46 (10%) were transferred to a psychiatric hospital after resolution of their acute poisoning. Twenty patients (13 male, 7 female) died in hospital; 18 of these required level 3 care and two required level 2 care. Eight patients died from paracetamol-induced fulminant hepatic failure (seven were considered unsuitable for liver transplantation, and one died while awaiting super-urgent liver transplantation). Five patients died after presenting in cardiac arrest related to ingestion or injection of an opioid. Two patients died from hypotension refractory to treatment (one following metformin ingestion, the other following verapamil ingestion in the presence of significant coronary artery disease). One patient died from insulin-induced hypoglycaemic brain injury. One patient died in multiple organ failure resulting from colchicine overdose and one elderly patient presented with coincident paracetamol overdose and acute myocardial infarction. The median (IQR) age of the patients who died was 44 (37, 56) [range 24-87] years. The median (IQR) APACHE II score (n=18) was 26 (17, 28) and predicted mortality 55% (18, 72) . Median (IQR) length of survival in ICU was 0.9 (0.5, 2.7) days.
Investigations
Paracetamol was detected in 79 of the 417 patients in whom it was measured. Salicylate was detected in 31 of the 392 patients in whom it was measured. However, the plasma salicylate concentration exceeded 250 mg/L in only three patients.
Urine samples were assessed by immunoassay screening for the presence of benzodiazepine, opioid, methadone, cannabinoid, cocaine and amphetamine in 133 patients. Positive results for at least one of these substances were obtained in 106 (80%) samples. Benzodiazepines were detected in 81 samples, opioid in 47, methadone in 25, cannabinoid in 35, cocaine in 15, and amphetamine in 12.
A CT brain scan was performed in 176 patients (37%), the indications for which are shown in Table 3 . Abnormalities were reported in 23 patients but only six patients had acute changes (cerebral oedema with loss of grey/white matter differentiation; lacunar infarct; bilateral infarction in the internal capsule; globus pallidus changes; small fronto-parietal subarachnoid haemorrhage; supraorbital haematoma). CT findings did not influence the acute management of any patient.
Costs
A total of 950 ICU bed days (785 level 3 and 165 level 2) were used by 481 patients. Using a base cost of £1,011 per level 3 bed day and £652 per level 2 bed day, the cost of admitting these patients to intensive care was £901,215. This equates to a mean cost of £1,873 per patient.
Discussion Treatment and outcomes
Although self-poisoning is a common reason for hospital admission, 1,2 few poisoned patients require admission to ICU.
Patients with self-poisoning account for between 3.4% and 17.3% of ICU admissions, with most studies finding an incidence of 3-6% (Table 4) . 4, 8, 9, 16, 17 The great majority (96-99%) of patients survive, 4, 8, 9, 16, 17 although one study from Ireland found a mortality rate of nearly 26%. 15 Our findings that poisoned patients represent 3.8% of patients admitted to ICU with a mortality rate of 4% are in keeping with previous studies.
Many patients require short term (ie <12 hr) tracheal intubation, usually only for airway protection, and few require additional organ support such as inotropic or renal replacement therapy. Indeed 58 (12%) of patients in our study were discharged directly home from ICU after psychiatric evaluation. The vast majority of patients admitted to ICU after poisoning have no requirement for longer term medical treatment although some require transfer to a psychiatric unit for further evaluation and management.
Of the 20 patients (4%) who died in our study, death was probably inevitable in 19 primarily related to unsurvivable brain or hepatic injury, or poisoning with substances for which no effective therapy was available. (7) Cardiac medication 49 (11) 32 (11) 17 (9) Anticonvulsants 35 (7) 17 (6) 18 (9) Sleeping medication 20 (4) 7 (2) 13 (7) There is marked heterogeneity between the previously studied populations of patients admitted to ICU after selfpoisoning. Schwake and colleagues described patients admitted to a specialist gastroenterology and regional toxicology ICU where only 8% of patients had tracheal intubation and ventilation. 8 In contrast, 70-80% of patients admitted to ICUs in Australia 9 , Hong Kong and China 4 were ventilated, similar to the 69% in our study. This difference could reflect differing practice in patient management, or differing patient populations. Most studies report a mean age of patients of between 32 and 40 years 4, 8, 9, [15] [16] [17] and a higher rate of self-poisoning in females. 4, 8, 9, 16 We found a higher percentage of males (59%), which we believe is due to the increasing prevalence of recreational drug and opioid misuse. This is supported by two small studies from Ireland 15 and Australia 17 where the male:female ratio was >2:1 and prevalences of recreational and opioid drugs were around 27% and 48% respectively.
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Pattern of drug use
The pattern of drugs used in self-poisoning changes over time and varies between different countries ( Table 4 ). The contribution of household substances and carbon monoxide varies greatly throughout the world with high rates in Asia 4-6 and very low rates in Australia 9,17 and Europe, 7, 8, 15 as we confirmed in this study. In the 1980s, Strøm and colleagues found that three drugs (barbiturates, tricyclic antidepressants (TCAs) and propoxyphene) accounted for almost 60% of admissions to a Scandinavian ICU. 19 In the 1990s an Australian study 9 found that benzodiazepines and TCAs each accounted for more than 30% of ICU admissions. Barbiturates were almost absent, a finding sustained in a more recent German study. 8 Although the rate of admissions following benzodiazepine use had been fairly static between 30-40%, 8, 9, 15, 17 we found a rate almost half that in our present study. In contrast, admissions due to opioid use appear to have increased with time: 5% in the 1990s, 9 13% in 2000 8 and 25% in our study (if heroin and methadone are included). Other studies since 2000 have found an even higher incidence of opioid use in self-poisoning. 15, 17 This increase follows the trend in Scotland throughout the 1990s, where rates of opioid poisoning rose rapidly. 11 Another temporal change confirmed by this study is of the Table 4 Comparison of previous studies of patients admitted to ICU after self-poisoning. Age in years is shown as mean unless *median.
incidence of alcohol use by these patients, doubling from 20% to around 40% since the 1990s. 4, [8] [9] [10] Of even more concern is that 37 patients in this study required admission to ICU having misused alcohol alone, with no other drugs ingested.
In keeping with other studies since 2000 15, 17, 20 we have identified recreational drug use as an increasing problem. In this study 110 patients were admitted owing to poisoning with recreational drugs, most commonly heroin, methadone and GHB/GBL. Poisoning with recreational drugs was much more common in young men. In total, 147 (31%) of patients in our study were admitted after ingestion of alcohol alone or recreational drugs. It is likely that the number of patients admitted after drug misuse is even higher, as we have not included those who may have taken benzodiazepines or dihydrocodeine.
The emergence of GHB and GBL use as a cause for ICU admission is concerning. Although some consider GHB is not dangerous due to its very short half-life, 21 a series of over 200 deaths related to GHB use has recently been described 22 and although not captured in this study, further patients have required admission to the RIE ICU with acute GHB withdrawal. It will be important for future studies assessing the impact of any interventions for substance misuse to consider their effect on rates of ICU admission.
Investigation of poisoned patients
A logical and cost-effective investigation strategy is important when managing poisoned patients in whom full physical recovery is the norm with only supportive therapy and the use of few specific antidotes, particularly N-acetylcysteine for paracetamol poisoning.
Eighty-seven per cent of the patients in our study were tested for paracetamol and 81% for salicylates, with 19% and 8% returning positive results respectively. Widespread testing for paracetamol poisoning is essential as no pattern of symptoms and signs is evident in patients presenting soon after ingestion and N-acetylcysteine is most effective when given before hepatotoxicity has developed. 23 However, this study calls into further doubt the utility of generalised screening for salicylate poisoning, even in critically ill poisoned patients. 24, 25 Only three patients out of 392 tested had a significantly raised serum salicylate concentration and this was expected clinically in all three of these patients. We would echo national recommendations that there is no need to measure salicylate concentrations in conscious overdose patients who deny taking salicylate-containing preparations and who have no features suggestive of salicylate toxicity. 18 Similarly, 133 patients (28%) had urinary toxicology screening performed and these tests were positive in 80%. Urinary toxicology screens can be difficult to interpret. A positive result does not prove that a patient' s clinical features are due to that compound and several important compounds such as GHB and GBL cannot be detected. Also, the results of these are usually available after the patient has been discharged from intensive care, so rarely affect acute management. 26 We would suggest that unless being used for forensic reasons or to select patients for lifestyle modification interventions, the use of urinary toxicology screening should be limited to clinical situations where a patient' s condition is undiagnosed, is failing to improve and is compatible with poisoning, as suggested by the US National Association of Clinical Biochemists. 27 In this situation, close cooperation with the local biochemistry laboratory is essential to obtain optimum use of these assays.
CT scans were performed on 176 patients (37%) in this study, only six of which revealed acute abnormalities (3.4%) and none of which influenced acute management. This finding is difficult to interpret, as most poisoned patients in whom significant potentially reversible intracranial pathology was discovered in the RIE ED would be transferred directly to the local neurosurgical ICU. It is clear however that in this young population, where the risks from iatrogenic radiation exposure are potentially greatest, the use of CT brain scanning is widespread with many scans not affecting patient management. Future research is needed to establish a clinical decision rule for CT head use in poisoning. This is especially important for the 5% of severely poisoned patients admitted comatose to the ICU on multiple occasions.
Costs
In our study, 306 patients remained in intensive care less than 24 hours and a further 118 required a stay of less than 48 hours. In total, patients occupied 950 intensive care bed days, costing around £900,000. The mean cost of managing these patients was £1,873. This compares with an average cost of US $821 (£530) in Turkey 6 and Australian $5,303 (£3,341) in Australia. 17 The differences in these costs could be accounted for by differences between the populations of patients studied, substances ingested, intensive care interventions such as mechanical ventilation, and length of ICU stay.
Limitations
We acknowledge the limitations of a retrospective observational study from a single centre. Selection of patients via the Wardwatcher TM database may risk excluding some patients if poisoning was only a subsidiary reason for their admission to intensive care. Also, we cannot provide analytical confirmation of poisoning in a proportion of these patients as this is not our normal clinical practice. This may bias our results with 'toxi-dromes' being attributed to drugs commonly encountered by the physicians managing each patient. However, to our knowledge this is the largest series of patients admitted to ICU after self-poisoning in the UK and our findings are supported by studies from the past 10 years.
Summary
In conclusion we found that self-poisoning accounts for about 4% of admissions to ICU, many patients require only shortterm tracheal intubation, few require additional organ support and outcome is generally good. The demography of patients admitted to ICU after self-poisoning and the substances involved are changing with the prevalence of alcohol, recreational drugs and opioids increasing. This has significant implications for society and health care now and in the future.
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